Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Case Control Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine

NCT07009847 is registered in ClinicalTrials.gov with Serum Institute of India Pvt. Ltd. as lead sponsor.

NCT NCT07009847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07009847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Case Control Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine
Lead sponsor
Serum Institute of India Pvt. Ltd.
Phase
Observational
Overall status
Recruiting
Start date
June 16, 2025
Completion date
December 31, 2026
Enrollment
2,308 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

malaria,falciparum, morality